📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
328 announcements match the current filters (relevance ≥ 5).
UltraTech Cement Seeks Approval for ₹9,820 Crore Transactions with India Cements
UltraTech Cement has issued a postal ballot notice to seek shareholder approval for material related party transactions with its subsidiary, The India Cements Limited. The proposed transactions are capped at an aggregate limit of ₹9,820 crore for the financial year 2026-27. These dealings follow UltraTech's strategic acquisition of India Cements and are intended to be conducted at arm's length in the ordinary course of business. Shareholders can cast their votes via remote e-voting between May 1 and May 30, 2026.
Key Highlights
Proposed related party transactions with The India Cements Limited (ICEM) up to ₹9,820 crore.
Transactions are planned for the upcoming financial year 2026-27.
Remote e-voting period is scheduled from May 1, 2026, to May 30, 2026.
The resolution is an Ordinary Resolution based on recommendations from the Audit Committee and Board.
Results of the postal ballot will be announced on or before June 2, 2026.
👀 What to Watch
Investors should monitor the nature of these transactions as they reflect the scale of operational integration between UltraTech and its newly acquired subsidiary. No immediate portfolio changes are recommended, but shareholders are encouraged to participate in the e-voting process.
Panacea Biotec Wins Tax Appeal; ITAT Cancels ₹9.16 Crore Demand
Panacea Biotec has received a favorable ruling from the Income Tax Appellate Tribunal (ITAT) regarding Assessment Year 2020-21. The ITAT set aside a previous order that had raised a tax demand of ₹9.16 Crore. This demand was originally based on a ₹3.44 Crore disallowance of expenses under Section 14A of the Income Tax Act. The ruling effectively cancels the entire demand, providing a positive financial impact for the company by removing this liability.
Key Highlights
ITAT set aside the CIT(A) order dated August 14, 2025, for Assessment Year 2020-21
Cancellation of a tax demand amounting to ₹9.16 Crore
Deletion of expense disallowance of ₹3.44 Crore previously added under Section 14A
The ruling follows a Rectified Assessment Order originally passed on October 10, 2023
👀 What to Watch
This is a positive development as it removes a contingent liability and improves the company's financial position. Investors should continue to monitor the company's core business performance alongside such legal resolutions.
UltraTech Cement Releases Investor Presentation for Q4 and FY26 Performance
UltraTech Cement has filed its investor presentation for the quarter and full financial year ended March 31, 2026. The document provides a comprehensive review of the company's operational performance and financial health for the 2025-26 fiscal period. This disclosure is critical for understanding the company's market leadership and capacity utilization trends. The presentation has been shared across multiple international exchanges, including BSE, NSE, Luxembourg, and Singapore.
Key Highlights
Performance update for the quarter ended 31st March, 2026.
Full-year financial and operational review for the fiscal year 2025-26.
Multi-exchange disclosure including Luxembourg Stock Exchange and Singapore Exchange.
Official communication from the Company Secretary regarding performance records.
👀 What to Watch
Investors should download the full presentation to analyze EBITDA per ton and volume growth metrics. Focus on management's guidance for capacity expansion and demand outlook for the next fiscal year.
UltraTech Cement Recommends Rs 240 Dividend and Approves FY26 Annual Financial Results
UltraTech Cement's Board has approved the audited financial results for the fiscal year ending March 31, 2026. A major highlight for shareholders is the recommendation of a substantial dividend of Rs 240 per equity share (2400% of face value). The consolidated results now fully incorporate the performance of The India Cements Limited, which became a subsidiary in December 2024. While the company continues to contest a legacy CCI penalty of over Rs 1,800 crore, the matter remains stayed by the Supreme Court with no immediate provision required.
Key Highlights
Recommended a final dividend of Rs 240 per equity share (2400%) for the financial year ended March 31, 2026.
Approved both Standalone and Consolidated Audited Financial Results for FY26 with unmodified audit opinions.
Consolidated results include the impact of the acquisition of The India Cements Limited, effective December 24, 2024.
Maintained a deposit of Rs 180.43 crore (10% of penalty) against a stayed CCI order of Rs 1,804.31 crore.
The Board meeting concluded with the approval of several new subsidiaries and step-down entities across global markets.
👀 What to Watch
Investors should view the high dividend payout as a sign of strong cash flow and management confidence. Monitor the detailed earnings release for specific volume growth and margin performance following the India Cements integration.
UltraTech Cement Recommends Final Dividend of Rs. 240 Per Share for FY26
UltraTech Cement's Board of Directors has recommended a final dividend of Rs. 240 per equity share for the financial year ended March 31, 2026. This represents a significant 2400% payout on the face value of Rs. 10 per share, subject to shareholder approval at the upcoming AGM. The company also approved its audited financial results for FY26, which now consolidate major acquisitions including The India Cements Limited. Despite the positive dividend news, the company continues to contest Competition Commission of India penalties totaling over Rs. 1,872 crore in the Supreme Court.
Key Highlights
Recommended a final dividend of Rs. 240 per equity share (2400% of face value) for FY26
Approved Standalone and Consolidated Audited Financial Results for the year ended March 31, 2026
Consolidated results include newly acquired entities such as The India Cements Limited (w.e.f. Dec 2024)
Ongoing legal contingency regarding CCI penalties of Rs. 1,804.31 crore and Rs. 68.30 crore currently stayed by Supreme Court
👀 What to Watch
Investors should benefit from the substantial dividend payout and should review the detailed FY26 earnings report to assess the integration impact of recent acquisitions like India Cements.
UltraTech Cement Recommends Rs 240 Dividend (2400%) for FY26; Approves Annual Results
UltraTech Cement's Board has recommended a substantial dividend of Rs 240 per equity share for the financial year ended March 31, 2026. The company approved its audited standalone and consolidated financial results for the full year, which now include The India Cements Limited as a subsidiary. While the company faces a significant CCI penalty of Rs 1,804.31 crores, it remains stayed by the Supreme Court with no provision currently made. The high dividend payout indicates strong cash flow and management's commitment to shareholder returns.
Key Highlights
Recommended a dividend of 2400% at the rate of Rs 240 per equity share of Rs 10 each.
Approved audited standalone and consolidated financial results for the fiscal year ended March 31, 2026.
The India Cements Limited is now reflected as a subsidiary in the consolidated results effective December 24, 2024.
Ongoing legal dispute regarding CCI penalties totaling approximately Rs 1,872.61 crores remains stayed by the Supreme Court.
👀 What to Watch
Investors should benefit from the high dividend payout and should review the detailed financial statements to assess the impact of the India Cements acquisition on overall margins. Monitor the Supreme Court proceedings regarding the CCI penalty as it remains a significant contingent liability.
India Cements Reports Turnaround with Q4 PAT of ₹70 Cr and ₹2,000 Cr Capex Plan
The India Cements Limited demonstrated a strong recovery in Q4 FY26, reporting a PAT of ₹70 Crores before exceptional items, compared to a loss of ₹75 Crores in the previous year. Domestic sales volume grew 18% YoY to 3.12 MnT, supported by an 11% increase in capacity utilization to 84%. The company announced a major ₹2,000 Crore capex plan for the next two years to expand capacity by 2.8 Mtpa and improve process efficiencies. Furthermore, a strategic shift toward green power is underway, aiming to reach 80% renewable and WHRS energy by FY29.
Key Highlights
Q4 FY26 PAT (before exceptions) reached ₹70 Crores vs a loss of ₹75 Crores in Q4 FY25.
Operating EBITDA per tonne improved significantly to ₹497 from ₹305 in the previous quarter.
Net realization increased 6.2% YoY to ₹3,791/Mt, while fuel costs declined by 16% YoY.
Announced ₹2,000 Crore capex for 2.8 Mtpa capacity expansion and plant modernization.
Targeting a massive scale-up of green power from 6% currently to 80% by FY29.
👀 What to Watch
Investors should note the successful operational turnaround and the aggressive efficiency-led capex plan which could drive long-term margin expansion. Monitor the execution of the capacity expansion and the company's ability to maintain high utilization rates amidst competitive pressures.
India Cements Returns to Profit in FY26 with ₹65.32 Cr Net Profit; Revenue Up 10%
The India Cements Limited reported a significant financial turnaround for the fiscal year ended March 31, 2026, posting a net profit of ₹65.32 crore compared to a loss of ₹655.65 crore in FY25. Revenue from operations grew by 9.9% to ₹4,484.69 crore, supported by a sharp 62.8% reduction in finance costs which fell to ₹99.33 crore. The company also completed the amalgamation of four subsidiaries and divested its stake in ICML for ₹97.68 crore. While operational performance has improved, the company still faces legal overhangs including a ₹187.48 crore CCI penalty currently under appeal.
Key Highlights
Annual Revenue from Operations increased to ₹4,484.69 crore in FY26 from ₹4,080.39 crore in FY25.
Turned profitable with a Net Profit of ₹65.32 crore for FY26 against a Net Loss of ₹655.65 crore in the previous year.
Finance costs significantly reduced to ₹99.33 crore from ₹267.17 crore year-on-year.
Successfully completed the amalgamation of four wholly-owned subsidiaries effective March 28, 2026.
Divested entire equity holding in subsidiary ICML for a total consideration of ₹97.68 crore.
👀 What to Watch
Investors should view the return to profitability and the massive reduction in interest costs as a strong sign of operational recovery. However, keep a close watch on the final resolution of the CCI penalty and the ongoing integration benefits as a subsidiary of UltraTech Cement.
Pace Digitek Signs Exclusive OEM Deal with NEC XON for BESS Expansion in 5 African Nations
Pace Digitek Limited has entered into an exclusive Original Equipment Manufacturer (OEM) agreement with NEC XON Systems to market and distribute its Battery Energy Storage Systems (BESS). The partnership covers five key African markets: South Africa, Botswana, Mozambique, Namibia, and Mauritius. This strategic move allows Pace Digitek to leverage NEC XON's established regional infrastructure while focusing on its core manufacturing and product development capabilities. The collaboration aims to capture high-growth opportunities in grid-scale energy storage and renewable integration across the African continent.
Key Highlights
Exclusive OEM partnership for BESS distribution across 5 African territories: South Africa, Botswana, Mozambique, Namibia, and Mauritius.
NEC XON will serve as the go-to-market and deployment partner, while Pace Digitek focuses on manufacturing and supply.
The agreement marks Pace Digitek's formal entry into international markets through a scalable, partner-led model.
Targets high-growth demand for grid-scale energy storage and reliable power infrastructure in the African region.
Leverages the global network of NEC Corporation, which has a footprint spanning over 50 countries.
👀 What to Watch
Investors should monitor the impact of this partnership on the company's order book and export revenue growth over the next few quarters. This expansion into the BESS segment in international markets significantly enhances the company's growth profile beyond its domestic telecom and energy operations.
Pace Digitek Signs Exclusive OEM Agreement with NEC XON for 5 African Markets
Pace Digitek Limited has entered into an exclusive Original Equipment Manufacturer (OEM) agreement with NEC XON Systems Proprietary Limited. This partnership grants NEC XON exclusive rights to market, distribute, and sell the company's Battery Energy Storage Systems (BESS) and related energy solutions. The agreement covers five strategic territories: South Africa, Botswana, Mozambique, Namibia, and Mauritius. This move represents a significant international expansion for the company's energy storage business segment.
Key Highlights
Exclusive OEM agreement signed with NEC XON Systems Proprietary Limited on April 22, 2026.
Focuses on marketing and distribution of Battery Energy Storage Systems (BESS) and energy solutions.
Grants exclusive rights across South Africa, Botswana, Mozambique, Namibia, and Mauritius.
The partnership leverages an international entity to scale distribution in high-demand energy markets.
The agreement is executed at arm's length with no promoter or group company involvement.
👀 What to Watch
Investors should view this as a positive step toward globalizing the company's BESS portfolio and should monitor future quarterly reports for revenue growth from these African territories.
Pace Digitek Seeks Approval for ₹4,325 Cr Related Party Transaction with Lineage Power
Pace Digitek Limited has issued a postal ballot notice to seek shareholder approval for several material related party transactions (RPTs) for the financial year 2026-27. The most significant proposal involves a transaction limit of up to ₹4,325 crore with its material unlisted subsidiary, Lineage Power Private Limited. Approval is also sought for transactions with five other related entities, including Pace Ecoplanet Solace and Pace Renewable Energies. The e-voting period for these resolutions is set from April 24 to May 23, 2026.
Key Highlights
Proposed material RPT with Lineage Power Private Limited capped at ₹4,325 crore for FY 2026-27.
Shareholder approval sought for transactions with six different related entities via postal ballot.
E-voting period scheduled from April 24, 2026, to May 23, 2026, with results by May 26.
Transactions are stated to be at arm's length and in the ordinary course of business.
Cut-off date for eligibility to participate in the e-voting was April 21, 2026.
👀 What to Watch
Investors should review the explanatory statement to ensure the terms of these high-value transactions are fair and do not disadvantage minority shareholders. Monitor the voting results on May 26 to gauge shareholder confidence in management's related-party dealings.
Pace Digitek to Seek Approval for Material Related Party Transactions; Appoints Senior Management
Pace Digitek Limited has announced several key governance and leadership updates following its board meeting on April 22, 2026. The company is seeking shareholder approval via postal ballot for material related party transactions with six different entities, including Pace Renewable Energies and Lanarsy Infra. To strengthen its energy business vertical, the board designated Himanshu Goyal and Nishant Raj as Senior Management Personnel, bringing 12 and 15 years of industry experience respectively. Additionally, M/s. K. S Kamalakara & Co has been re-appointed as the Cost Auditor for the 2026-27 fiscal year.
Key Highlights
Authorized postal ballot for material related party transactions with 6 entities including Lineage Power and Lanarsy Infra.
Designated Himanshu Goyal (12 years experience) and Nishant Raj (15 years experience) as Senior Management Personnel.
Re-appointed M/s. K. S Kamalakara & Co as Cost Auditors for the Financial Year 2026-27.
The new management appointments focus specifically on Energy Projects, Operations, and Commercial Strategy.
👀 What to Watch
Investors should closely examine the upcoming postal ballot notice to understand the scale and terms of the material related party transactions. The addition of experienced leadership in the energy segment is a positive step for project execution and business development.
UltraTech Cement Commissions 8.7 MTPA Capacity; Domestic Capacity Hits 200.1 MTPA Milestone
UltraTech Cement has successfully commissioned 8.7 mtpa of new cement grinding capacity across three strategic locations in Uttar Pradesh, Andhra Pradesh, and Jharkhand. This expansion pushes the company's total domestic grey cement capacity to a significant milestone of 200.1 mtpa. With global capacity now reaching 205.5 mtpa, the company solidifies its position as the world's largest cement manufacturer by sales volume outside of China. This capacity addition is expected to strengthen market share and cater to growing infrastructure demand.
Key Highlights
Commissioned 8.7 mtpa capacity across Shahjahanpur (2.7 mtpa), Visakhapatnam (3.0 mtpa), and Patratu (3.0 mtpa)
Total domestic grey cement manufacturing capacity now stands at 200.1 mtpa
Global capacity, including overseas units, has reached 205.5 mtpa
Maintains status as the largest single-country cement manufacturer globally, excluding China
👀 What to Watch
Investors should view this as a strong growth signal that reinforces UltraTech's market leadership and scale. The stock remains a key play on India's infrastructure and housing growth story.
UltraTech Cement Crosses 200 MTPA Capacity; World's Largest Outside China
UltraTech Cement has achieved a major milestone by crossing 200 MTPA of installed cement capacity in India following the commissioning of three new grinding units with a cumulative capacity of 8.7 MTPA. The company's total consolidated global capacity now stands at 205.5 MTPA, making it the largest cement producer globally outside of China. Notably, the company doubled its capacity from 100 MTPA to 200 MTPA in less than seven years, reflecting high execution speed. Looking ahead, UltraTech is targeting a capacity of 240+ MTPA, supported by an ongoing capital expenditure of over Rs. 16,000 crore.
Key Highlights
Commissioned 3 new grinding units in UP, Jharkhand, and Andhra Pradesh with 8.7 MTPA cumulative capacity
Total India capacity reached 200.1 MTPA and consolidated global capacity reached 205.5 MTPA
Achieved the second 100 MTPA of capacity in less than 7 years compared to 36 years for the first 100 MTPA
On track to reach 240 MTPA capacity with an ongoing capex investment of over Rs. 16,000 crore
Strengthened market leadership as the world's largest cement company outside China
👀 What to Watch
Investors should view this milestone as a testament to UltraTech's superior execution capabilities and dominant market position. The aggressive expansion roadmap to 240 MTPA provides strong long-term growth visibility in India's infrastructure-led economy.
Pace Digitek Secures ₹64,597 Million Orders in FY26; Energy Segment Drives 90% of Growth
Pace Digitek reported a massive order inflow of ₹64,597 million for FY2026, with the energy business emerging as the primary growth engine. The energy segment contributed ₹58,147 million, driven by Battery Energy Storage Systems (BESS) and renewable projects. Notably, 42% of energy orders are Build Own Operate (BOO) contracts, which provide long-term annuity-linked revenue. The telecom segment remains stable, contributing ₹6,450 million through O&M and infrastructure projects for major clients like BSNL and Indian Railways.
Key Highlights
Total FY26 order inflows reached ₹64,597 million, providing multi-year execution visibility.
Energy segment dominated with ₹58,147 million, focusing on BESS and renewable energy transitions.
BOO contracts worth ₹24,550 million (42% of energy mix) ensure long-term cash flow visibility.
EPC contracts worth ₹30,484 million (52% of energy mix) offer strong near-to-mid-term execution visibility.
Diversified client base includes major public entities like NTPC, SECI, KPTCL, and Indian Railways.
👀 What to Watch
Investors should view this as a strong growth signal, particularly the strategic shift towards high-margin BESS and BOO projects. Monitor the company's execution efficiency and margin profile as these large-scale energy projects move into the implementation phase.
Ambuja Cements Board to Meet May 4 for Q4 FY26 Results and Dividend Recommendation
Ambuja Cements has scheduled a board meeting on May 4, 2026, to approve the audited standalone and consolidated financial results for the quarter and full year ended March 31, 2026. The board will also consider recommending a dividend for the financial year 2025-26 during this session. An earnings conference call is scheduled for the same day at 5:00 PM IST featuring the CEO and CFO to discuss the business outlook. The trading window for the company's securities remains closed from April 1, 2026, until 48 hours after the results are announced.
Key Highlights
Board meeting set for May 4, 2026, to finalize Q4 and FY26 audited financial results.
Potential dividend recommendation for FY 2025-26 to be discussed by the board.
Earnings conference call scheduled for May 4, 2026, at 5:00 PM IST with top management.
Trading window for insiders closed from April 1, 2026, to May 6, 2026.
Key management participants include CEO Vinod Bahety and CFO Rohit Soni.
👀 What to Watch
Investors should monitor the May 4 announcement for the dividend yield and management's commentary on volume growth and cost synergies. Maintain current positions while awaiting the full financial performance report.
UltraTech Cement Reaffirmed 'CARE AAA; Stable' Rating; Capacity to Reach 240.8 MTPA by FY28
CARE Ratings has reaffirmed UltraTech Cement's 'CARE AAA; Stable' and 'CARE A1+' ratings, underscoring its position as India's largest cement producer with a total capacity of 194.06 MTPA. The company reported strong 9MFY26 performance with net sales rising 19% YoY to ₹62,712 crore and EBITDA margins expanding to 19%. Despite recent debt-funded acquisitions and capex, the net debt to PBILDT ratio is expected to improve from 1.89x in FY25 to approximately 1.3x in FY26. The company is aggressively expanding towards a 240.8 MTPA target by FY28 while diversifying into the cables and wire segment.
Key Highlights
CARE Ratings reaffirmed 'CARE AAA; Stable' for ₹17,100 crore in bank facilities and withdrew the fixed deposit rating due to full repayment.
Total grey cement capacity stands at 194.06 MTPA as of December 2025, with a clear roadmap to reach 240.8 MTPA by FY28.
9MFY26 EBITDA increased significantly to ₹11,910 crore from ₹7,945 crore in the previous year, driven by volume growth and cost efficiencies.
Net debt to PBILDT is projected to reduce to ~1.3x in FY26, supported by strong operational cash flows and limited incremental debt.
The company is investing ₹1,800 crore in a new cables and wire division and aims for 60% green power usage by FY27-end.
👀 What to Watch
Investors should take confidence in the reaffirmed highest credit rating, which validates the company's ability to manage large-scale expansions and acquisitions without compromising financial stability. The stock remains a core play on India's infrastructure growth, supported by industry-leading margins and a strengthening balance sheet.
Panacea Biotec Secures INR 20.79 Crore Vaccine Supply Order from CMSS
Panacea Biotec Limited has received a Letter of Award from the Central Medical Services Society (CMSS), under the Ministry of Health and Family Welfare, for the supply of Diphtheria and Tetanus (Td) vaccines. The total value of the contract is INR 20.79 Crore. The supply is scheduled to be executed in multiple tranches starting from September/October 2026 and concluding by November/December 2028. This domestic order provides long-term revenue visibility for the company's vaccine segment.
Key Highlights
Total contract value aggregates to INR 20.79 Crore for Td Vaccine supply
Order awarded by Central Medical Services Society (CMSS), a domestic government entity
Execution timeline spans approximately two years from late 2026 to late 2028
The contract involves Diphtheria and Tetanus Vaccine (Absorbed) for Adults and Adolescents IP
👀 What to Watch
Investors should note this as a positive development for revenue stability, though the execution starts in late 2026. Monitor the company's ability to secure similar high-volume government contracts to improve its order book.
Ambuja Cements Allots 1.29 Crore Equity Shares to Sanghi Industries Shareholders
Ambuja Cements has officially approved the allotment of 1,29,93,708 equity shares to the shareholders of Sanghi Industries Limited (SIL) as part of their Scheme of Arrangement. This issuance, finalized on April 10, 2026, follows the share exchange ratio defined in the merger agreement. The new shares carry a face value of Rs. 2 each and will rank pari passu with existing equity. This move marks a critical step in the Adani-owned company's consolidation of Sanghi Industries into its operations.
Key Highlights
Allotment of 1,29,93,708 fully paid-up equity shares of face value Rs. 2 each.
Shares issued to eligible shareholders of Sanghi Industries Limited (SIL) as per the Scheme of Arrangement.
Includes 15,156 shares allotted to Catalyst Trusteeship Limited to manage fractional entitlements.
New shares will be listed on both BSE and NSE and rank equally with existing shares.
The allotment was approved by the Finance Committee in a meeting held on April 10, 2026.
👀 What to Watch
Investors should monitor the listing of these new shares and focus on the synergy benefits and capacity expansion resulting from the Sanghi Industries integration. The successful share allotment indicates the merger is proceeding according to the regulatory timeline.
Ambuja Cements Allots 1.29 Crore Equity Shares to Sanghi Industries Shareholders
Ambuja Cements has successfully allotted 1,29,93,708 equity shares to the shareholders of Sanghi Industries Limited (SIL) as part of their Scheme of Arrangement. This allotment follows the strategic acquisition of SIL, aimed at strengthening Ambuja's market position in Western India. The new shares, with a face value of Rs. 2 each, will rank pari passu with existing shares and are set to be listed on the NSE and BSE. This move signifies a key execution milestone in the integration process of Sanghi Industries into the Adani-owned cement business.
Key Highlights
Allotment of 1,29,93,708 fully paid-up equity shares of face value Rs. 2 each.
Includes 15,156 shares allotted to Catalyst Trusteeship Limited to manage fractional entitlements.
New shares will rank pari passu with existing equity shares of Ambuja Cements.
The allotment was approved by the Finance Committee of the Board on April 10, 2026.
Shares are proposed to be listed and traded on both BSE Limited and National Stock Exchange of India Limited.
👀 What to Watch
Investors should view this as a positive step in the completion of the Sanghi Industries acquisition, which is expected to bring operational synergies. No immediate action is required, but monitor the integration's impact on Ambuja's overall production capacity and margins.
